Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-1995 | 07-1995 | 04-1995 | 01-1995 | 10-1994 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,458 | N/A | N/A | N/A | 4,018 |
| Depreciation Amortization | 3,520 | N/A | N/A | N/A | 3,083 |
| Other Working Capital | -8,501 | N/A | N/A | N/A | -7,113 |
| Other Operating Activity | 385 | 0 | 0 | 0 | -1,763 |
| Operating Cash Flow | $3,862 | $N/A | $N/A | $N/A | $-1,775 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,047 | N/A | N/A | N/A | -6,285 |
| Net Acquisitions | 0 | N/A | N/A | N/A | -1,571 |
| Other Investing Activity | 8,246 | 0 | 0 | 0 | -1,013 |
| Investing Cash Flow | $-7,801 | $N/A | $N/A | $N/A | $-8,869 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 3,776 | 0 | 0 | 0 | 11,932 |
| Financing Cash Flow | $3,776 | $N/A | $N/A | $N/A | $11,932 |
| Beginning Cash Position | 2,188 | N/A | N/A | N/A | 900 |
| End Cash Position | 2,025 | N/A | N/A | N/A | 2,188 |
| Net Cash Flow | $-163 | $N/A | $N/A | $N/A | $1,288 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,862 | N/A | N/A | N/A | -1,775 |
| Free Cash Flow | 3,862 | 0 | 0 | 0 | -1,775 |